SCHEDULE: August Luck Global Increases Universe Pharmaceuticals Stake

August Luck Global Limited and Xuefeng Li now collectively beneficially own 9.29% of Universe Pharmaceuticals INC's Class A ordinary shares.

Summary

• August Luck Global Limited, wholly owned by Xuefeng Li, has reported beneficial ownership of 465,258 Class A ordinary shares of Universe Pharmaceuticals INC.
• This holding represents 9.29% of the total outstanding Class A ordinary shares.
• The filing is a Schedule 13G, indicating a passive investment stake.
• The date of the event requiring this filing is July 27, 2026.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership without significant new financial or strategic information.

Positives

• Increased transparency regarding significant shareholding in Universe Pharmaceuticals INC.
• Confirmation of a substantial passive investment by August Luck Global Limited and Xuefeng Li.

Negatives

• No new financial performance data or strategic initiatives are disclosed in this filing.
• The filing does not provide insight into the reasons for the increased stake.

Risks

• Potential for future changes in beneficial ownership that could impact share price.
• The passive nature of the investment could change, leading to more active influence.

Future Outlook

This filing does not contain forward-looking statements or specific future guidance from the company.

Management Comments

• August Luck Global Limited is wholly owned and controlled by Xuefeng Li, an individual.
• The percentage of class is calculated based on 5,008,313 Class A ordinary shares outstanding as of July 27, 2026.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant individual shareholders accumulating stakes in publicly traded companies, often indicating a belief in the company's future prospects or a strategic investment position.

Stakeholder Impact

• Shareholders: Increased transparency regarding a significant passive shareholder may influence market perception.
• Management: Awareness of a substantial beneficial owner with a passive investment strategy.

Next Steps

• August Luck Global Limited and Xuefeng Li will continue to monitor their investment in Universe Pharmaceuticals INC.
• Further filings may be required if beneficial ownership changes significantly.

Key Dates

Keywords

Universe Pharmaceuticals, August Luck Global, Xuefeng Li, Schedule 13G, Beneficial Ownership, Class A ordinary shares, Investment Holding